ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Shares outstanding, 2025
- 132.6M
- YoY, 2025
- +2.4%
- 5-year CAGR
- +2.5%
- 10-year CAGR
- +4.5%
Shares outstanding
Shares outstanding by fiscal year
| Period | Shares outstanding | YoY |
|---|---|---|
| 2025 | 132.6M | +2.4% |
| 2024 | 129.5M | +2.8% |
| 2023 | 125.9M | +1.5% |
| 2022 | 124.1M | +3.3% |
| 2021 | 120.2M | +2.7% |
| 2020 | 117.0M | +3.9% |
| 2019 | 112.6M | +6.0% |
| 2018 | 106.3M | +6.4% |
| 2017 | 99.9M | +16.1% |
| 2016 | 86.0M | +1.0% |
| 2015 | 85.1M | +1.6% |
| 2014 | 83.8M | +31.0% |
| 2013 | 63.9M | +3.3% |
| 2012 | 61.9M | +43.2% |
| 2011 | 43.2M | +2.0% |
| 2010 | 42.3M | — |